COPD trials recruiting in Minnesota

All COPD trials nationally

Cities in Minnesota

Recruiting trials in Minnesota

• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
  NCT06883305 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Minnesota: Saint Cloud
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
  NCT06878261 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Minnesota: Minneapolis
• Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
  NCT05181826 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Coon Rapids, Fridley, Minneapolis
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
  NCT07190209 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Minnesota: Rochester
• Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
  NCT05025774 · Phase: Not specified · Ages: 8 Years to 25 Years · Sex: All (male and female) · Minnesota: Minneapolis
• Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
  NCT06390345 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Minneapolis
• Pulmonary Rehabilitation for Rural Patients With COPD
  NCT06847061 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · Minnesota: Rochester
• To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
  NCT07684820 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Minnesota: Maplewood
• myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
  NCT05204888 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years and older · Sex: All (male and female) · Minnesota: Minneapolis